BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 32560596)

  • 1. Response to Miyauchi
    Sawka AM; Baxter NN; Gafni A; Ezzat S; Goldstein DP;
    Thyroid; 2020 Oct; 30(10):1542-1543. PubMed ID: 32560596
    [No Abstract]   [Full Text] [Related]  

  • 2. Re: "A Prospective Mixed-Methods Study of Decision-Making on Surgery or Active Surveillance for Low-Risk Papillary Thyroid Cancer" by Sawka
    Miyauchi A; Ito Y; Davies L
    Thyroid; 2020 Oct; 30(10):1541-1542. PubMed ID: 32484054
    [No Abstract]   [Full Text] [Related]  

  • 3. A Prospective Mixed-Methods Study of Decision-Making on Surgery or Active Surveillance for Low-Risk Papillary Thyroid Cancer.
    Sawka AM; Ghai S; Yoannidis T; Rotstein L; Gullane PJ; Gilbert RW; Pasternak JD; Brown DH; Eskander A; Almeida JR; Irish JC; Higgins K; Enepekides DJ; Monteiro E; Banerjee A; Shah M; Gooden E; Zahedi A; Korman M; Ezzat S; Jones JM; Rac VE; Tomlinson G; Stanimirovic A; Gafni A; Baxter NN; Goldstein DP
    Thyroid; 2020 Jul; 30(7):999-1007. PubMed ID: 32126932
    [No Abstract]   [Full Text] [Related]  

  • 4. Decision Regret Following the Choice of Surgery or Active Surveillance for Small, Low-Risk Papillary Thyroid Cancer: A Prospective Cohort Study.
    Sawka AM; Ghai S; Rotstein L; Irish JC; Pasternak JD; Monteiro E; Chung J; Zahedi A; Su J; Xu W; Jones JM; Gafni A; Baxter NN; Goldstein DP
    Thyroid; 2024 May; 34(5):626-634. PubMed ID: 38481111
    [No Abstract]   [Full Text] [Related]  

  • 5. Re: "Active surveillance of low-risk papillary thyroid cancer: A meta-analysis".
    Cho SJ; Baek JH
    Surgery; 2020 May; 167(5):885-886. PubMed ID: 31810523
    [No Abstract]   [Full Text] [Related]  

  • 6. Invited Commentary: Patient-Reported Outcomes in Patients with Low-Risk Papillary Thyroid Carcinoma: Cross-Sectional Study to Compare Active Surveillance and Immediate Surgery.
    Miller BS
    World J Surg; 2023 May; 47(5):1199-1200. PubMed ID: 36648517
    [No Abstract]   [Full Text] [Related]  

  • 7. ASO Author Reflections: Active Surveillance may be Possible in Patients with T1b Papillary Thyroid Carcinoma Over 55 Years of Age Without High-Risk Features on Preoperative Examinations.
    Won HR; Jeon E; Heo DB; Chang JW; Shong M; Kim JR; Ko H; Kang YE; Yi HS; Lee JH; Joung KH; Kim JM; Lee Y; Kim SW; Jeong YJ; Ji YB; Tae K; Koo BS;
    Ann Surg Oncol; 2023 Apr; 30(4):2254-2255. PubMed ID: 36629990
    [No Abstract]   [Full Text] [Related]  

  • 8. Active Surveillance for T1bN0M0 Papillary Thyroid Carcinoma.
    Sakai T; Sugitani I; Ebina A; Fukuoka O; Toda K; Mitani H; Yamada K
    Thyroid; 2019 Jan; 29(1):59-63. PubMed ID: 30560718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment decision making in early-stage papillary thyroid cancer.
    D'Agostino TA; Shuk E; Maloney EK; Zeuren R; Tuttle RM; Bylund CL
    Psychooncology; 2018 Jan; 27(1):61-68. PubMed ID: 28124394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Active surveillance of low-risk papillary thyroid cancer: A meta-analysis-Methodologic critiques and tips for addressing them.
    Sawka AM; Thabane L
    Surgery; 2020 Nov; 168(5):975. PubMed ID: 32279893
    [No Abstract]   [Full Text] [Related]  

  • 11. Factors That Inform Individual Decision Making Between Active Surveillance, Hemithyroidectomy and Total Thyroidectomy for Low-Risk Thyroid Cancer: A Scoping Review.
    Wei J; Thwin M; Nickel B; Glover A
    Thyroid; 2022 Jul; 32(7):807-818. PubMed ID: 35438545
    [No Abstract]   [Full Text] [Related]  

  • 12. Applying Criteria of Active Surveillance to Low-Risk Papillary Thyroid Cancer Over a Decade: How Many Surgeries and Complications Can Be Avoided?
    Griffin A; Brito JP; Bahl M; Hoang JK
    Thyroid; 2017 Apr; 27(4):518-523. PubMed ID: 28125944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thyroidectomy vs Active Surveillance for Subcentimeter Papillary Thyroid Cancers--The Cost Conundrum.
    Kandil E; Noureldine SI; Tufano RP
    JAMA Otolaryngol Head Neck Surg; 2016 Jan; 142(1):9-10. PubMed ID: 26661274
    [No Abstract]   [Full Text] [Related]  

  • 14. A protocol for a Canadian prospective observational study of decision-making on active surveillance or surgery for low-risk papillary thyroid cancer.
    Sawka AM; Ghai S; Tomlinson G; Rotstein L; Gilbert R; Gullane P; Pasternak J; Brown D; de Almeida J; Irish J; Chepeha D; Higgins K; Monteiro E; Jones JM; Gafni A; Goldstein DP
    BMJ Open; 2018 Apr; 8(4):e020298. PubMed ID: 29654030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Active surveillance of low-risk papillary thyroid carcinoma: a promising strategy requiring additional evidence.
    Ze Y; Zhang X; Shao F; Zhu L; Shen S; Zhu D; Bi Y
    J Cancer Res Clin Oncol; 2019 Nov; 145(11):2751-2759. PubMed ID: 31571010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Clinical Framework to Facilitate Risk Stratification When Considering an Active Surveillance Alternative to Immediate Biopsy and Surgery in Papillary Microcarcinoma.
    Brito JP; Ito Y; Miyauchi A; Tuttle RM
    Thyroid; 2016 Jan; 26(1):144-9. PubMed ID: 26414743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The rising incidence of papillary thyroid cancer: More cancers or more assessments?
    Galuppini F; Pennelli G; Rugge M
    Indian J Cancer; 2019; 56(2):183-184. PubMed ID: 31062744
    [No Abstract]   [Full Text] [Related]  

  • 18. Active Surveillance Versus Immediate Surgery: Questionnaire Survey on the Current Treatment Strategy for Adult Patients with Low-Risk Papillary Thyroid Microcarcinoma in Japan.
    Sugitani I; Ito Y; Miyauchi A; Imai T; Suzuki S
    Thyroid; 2019 Nov; 29(11):1563-1571. PubMed ID: 31441377
    [No Abstract]   [Full Text] [Related]  

  • 19. Active Surveillance in Adults with Low-Risk Papillary Thyroid Microcarcinomas: A Prospective Study.
    Rosario PW; MourĂ£o GF; Calsolari MR
    Horm Metab Res; 2019 Nov; 51(11):703-708. PubMed ID: 31683339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mortality Risk of Nonoperative Papillary Thyroid Carcinoma: A Corollary for Active Surveillance.
    Ho AS; Luu M; Zalt C; Morris LGT; Chen I; Melany M; Ali N; Patio C; Chen Y; Mallen St-Clair J; Braunstein GD; Sacks WL; Zumsteg ZS
    Thyroid; 2019 Oct; 29(10):1409-1417. PubMed ID: 31407637
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.